370 filings
Page 4 of 19
8-K
x5fps
19 Aug 20
Mateon Therapeutics Selects IQVIA for its Randomized, Controlled, Multi-Center Clinical Study to Test OT-101 as a Treatment for COVID-19 Patients
6:20am
8-K
khy6k1dzz43yl
14 Aug 20
Submission of Matters to a Vote of Security Holders
12:00am
8-K
547fakim96j
13 Aug 20
Entry into a Material Definitive Agreement
5:15pm
8-K
fzz2lar4561c6q0s
3 Aug 20
Entry into a Material Definitive Agreement
8:43am
8-K
aabd30y8886 7kpkvejz
29 Jul 20
Mateon Therapeutics Closes $2.0 Million Financing
5:14pm
8-K/A
4aude8
22 Jun 20
Entry into a Material Definitive Agreement
9:00am
8-K
5vkm9suycu yt1z5hba
18 Jun 20
Other Events
10:30am
8-K
u60qqt6
16 Jun 20
Mateon Announces Achievement of Milestone Under Licensing of OT-101/IL-2 Combination to Autotelic Bio
6:58am
8-K
700o7gfw7nsm4
12 Jun 20
Mateon Announces an Expansion to Its Pharmaceutical Manufacturing Ai Camera Grid by Including Contact Tracing to Ensure Worker Safety
9:00am
8-K
lonu 1mhbg7
14 May 20
Departure of Directors or Certain Officers
5:22pm
8-K
ngi6hdhgh4 91nc3p
12 May 20
Mateon Provides Update on its R&D Effort Against COVID-19
10:56am
8-K
p798e5zl5
11 May 20
Other Events
8:18am
8-K
bj4rqll1orc6p7us
4 May 20
Other Events
9:00am
8-K
xwaok0p5xvxj5yf
29 Apr 20
Other Events
6:18am
8-K
rig9qiq8hs8h1uml8x1r
27 Apr 20
Entry into a Material Definitive Agreement
2:46pm
8-K
j2zhz1notb5p vfb4
24 Apr 20
Other Events
6:15am
8-K
u2e ys0dftnvj7o2g9pt
20 Apr 20
Regulation FD Disclosure
6:15am
8-K
05c42zzd9 b9myc6x
14 Apr 20
Other Events
1:03pm
8-K
vfm9z2ao03zp xlongck
14 Apr 20
Mateon Achieves Milestone In Its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19
6:16am
8-K
6wp0a095yhihz3
7 Apr 20
Other Events
3:00pm